ABVC: ABVC BioPharma Inc. P/S multiplikatori

ABVC BioPharma, Inc (ABVC) brendining ramzi va logotipi

GURU.Markets platformasidagi P/S tebranishlari yirik sog'liqni saqlash gigantlarining mavjudligida ABVC BioPharma duch kelayotgan bozor risklarini aks ettiradi, bunda joriy parametr 43.70 ga teng. ABVC BioPharma ADHD va depressiya uchun o'simliklarga asoslangan davolash vositalarini ishlab chiqadi va global litsenziyalash orqali sotuvlarni kengaytiradi. Aktivning qiymati o'sishi FDA tasdiqlari, patentlarning kengayishi va Osiyo hamkorlaridan keladigan to'lovlarga asoslangan.

abvcpharma.com - ABVC Kapitalizatsiyaning daromadga nisbati (davr: 04.07.2022 - 05.03.2026)

ABVC BioPharma Inc (ABVC) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:abvcpharma.com ABVC
ABVC BioPharma, Inc original mahsuloti

Professional menejerlar haddan tashqari qimmat baholangan aktivlarni o'sish potentsialiga ega bo'lganlardan ajratish uchun fundamental filtrlardan foydalanadilar. P/S koeffitsiyenti bozor kapitalizatsiyasini yillik daromad bilan solishtirib, aksiya narxi ichidagi bir rubl sotuvning tannarxini aniqlaydi. Investitsiyalar va tadqiqot natijalariga bog'liq bo'lgan ABVC BioPharma uchun ushbu metrika bozorning kelajakdagi mahsulotlardan kutayotganlarini aks ettiradi. P/S koeffitsiyenti grafigini tahlil qilish xavf va potentsial daromad muvozanatini saqlashga yordam beradi.

Raqobatdosh kompaniyalar

HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori KVUE (Kenvue)|P/S multiplikatori Verona Pharma PLC VRNA|Jyong Biotech Corp - P/S multiplikatori|LGND: Narxning daromadga nisbati|AMRX (Amneal Pharmaceuticals) - Kapitalizatsiyaning daromadga nisbati|PRGO (perrigo.com) - Narxning daromadga nisbati|ALVO (Alvotech SA) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Liquidia Corp (LQDA)|Kapitalizatsiyaning daromadga nisbati GLPG (Galapagos Genomics)|ANIP (ANI Pharmaceuticals Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori MNKD (MannKind Corporation)|amphastar.com - Narxning daromadga nisbati|Pacira BioSciences, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti ARS Pharmaceuticals Inc SPRY|Theravance (TBPH) - Narxning daromadga nisbati|Sotuvga nisbatan narx Aquestive Corp (AQST)|Narxning daromadga nisbati scPharmaceuticals, Inc.|Tectonic - Narxning sotuvga nisbati|P/S multiplikatori TNXP|SXTC (sxtchina.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EPRX (Eupraxia Pharmaceuticals Inc.)|P/S multiplikatori BioHarvest Sciences Inc BHST|EXOZ - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ORMP (Oramed Pharmaceuticals)|enterabio.com (ENTX) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati MindWalk Holdings, Inc.|CPIX (Cumberland Pharma) - P/S multiplikatori|P/S multiplikatori Quantum BioPharma Corp|P/S multiplikatori FGEN|P/S multiplikatori telomirpharma.com (TELO)|P/S multiplikatori RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. - Narxning daromadga nisbati|RLYB: Kapitalizatsiyaning daromadga nisbati|LEXX: Narxning daromadga nisbati|PULM: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pheton Holdings|Narxning daromadga nisbati Aptorum Group Ltd|Lyra Therapeutics Inc. - Narxning sotuvga nisbati|P/S multiplikatori IBO|TNFA (tnfpharma.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori YCBD (cbdMD)|P/S multiplikatori painreform.com PRFX|CYTO - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati LIPO (Lipella Pharmaceuticals Inc)|Optinose (OPTN) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Pieris Pharma|PROC (Procaps Group S.A.) - P/S multiplikatori|P/S multiplikatori petrospharma.com|Kapitalizatsiyaning daromadga nisbati QLI (Qilian International Holding)|SLRN (Acelyrin Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati TFF Pharma TFFP